No. 22-78
Bayer HealthCare Pharmaceuticals, Inc., et al. v. Curtis Ulleseit, et al.
Response Waived
Tags: circuit-split civil-procedure diversity-jurisdiction federal-courts federal-preemption fraudulent-joinder jurisdictional-review preemption summary-inquiry
Latest Conference:
2022-09-28
Question Presented (from Petition)
Whether courts may refuse to perform more than a summary inquiry to determine if defendants are fraudulently joined due to a pure issue of federal law.
Question Presented (AI Summary)
Whether courts may refuse to perform more than a summary inquiry to determine if defendants are fraudulently joined due to a pure issue of federal law
Docket Entries
2022-10-03
Petition DENIED.
2022-09-07
DISTRIBUTED for Conference of 9/28/2022.
2022-08-16
Waiver of right of respondents Curtis Ulleseit, Beth Winkler and Lisa Wehlmann to respond filed.
2022-07-25
Petition for a writ of certiorari filed. (Response due August 26, 2022)
2022-05-03
Application (21A673) granted by Justice Kagan extending the time to file until July 25, 2022.
2022-04-29
Application (21A673) to extend the time to file a petition for a writ of certiorari from May 26, 2022 to July 25, 2022, submitted to Justice Kagan.
Attorneys
Bayer HealthCare Pharmaceuticals Inc., et al.
Curtis Ulleseit, Beth Winkler and Lisa Wehlmann
Curtis Brooks Cutter — Cutter Law P.C., Respondent
C. Brooks Cutter — C. Brooks Cutter, Respondent